Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
1613028-81-1
S3I-201 significantly reduces viable cell numbers and inhibits growth of transformed mouse fibroblasts NIH 3T3/v-Src and breast carcinoma cell lines (MDA-MB-231
A Gunia-Krzyżak
(2003) Diabetes
mineralocorticoid
TBA-354 Catalog No.:M8471-2 1613028-81-1TBA 354, also known as SN31354, is a potent anti tuberculosis drug candidate. TBA 354 is narrow spectrum and bactericidal in vitro against replicating and nonreplicating Mycobacterium tuberculosis, with potency similar to that of delamanid and greater than that of PA 824. TBA 354 maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug sensitive and drug resistant isolates. TBA 354 is a promising
US$ 119.00
US$ 1622.00
US$ 60.00
US$ 84.99
US$ 60.00
US$ 60.00
US$ 199.00
US$ 44.99
US$ 107.00
US$ 57.99
US$ 650.00
US$ 54.99
US$ 330.00